当前位置:首页 - 行情中心 - 三元生物(301206) - 财务分析 - 现金流量表

三元生物

(301206)

  

流通市值:35.67亿  总市值:55.40亿
流通股本:1.30亿   总股本:2.02亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金544,775,312.94369,921,011.53172,819,121.39691,411,243.9
  收到的税费返还34,528,768.826,525,937.7217,852,236.5559,747,217.28
  收到其他与经营活动有关的现金11,245,269.714,852,660.123,434,909.984,340,986.25
  经营活动现金流入小计590,549,351.45401,299,609.37194,106,267.92755,499,447.43
  购买商品、接受劳务支付的现金468,868,978.81338,994,006.24125,529,484.03698,733,103.02
  支付给职工以及为职工支付的现金41,365,165.529,056,758.2315,900,322.5454,866,993.36
  支付的各项税费43,395,785.0922,289,607.376,518,314.293,066,162.08
  支付其他与经营活动有关的现金11,816,941.429,036,784.885,389,780.5812,482,699.36
  经营活动现金流出小计565,446,870.82399,377,156.72153,337,901.44769,148,957.82
  经营活动产生的现金流量净额25,102,480.631,922,452.6540,768,366.48-13,649,510.39
二、投资活动产生的现金流量:
  收回投资收到的现金8,363,400,0007,890,100,0005,604,000,000873,300,000
  取得投资收益收到的现金293,654,242.99292,042,664.91268,602,026.4834,781,299.82
  处置固定资产、无形资产和其他长期资产收回的现金净额63,6353,6352,500-
  收到的其他与投资活动有关的现金9,440,0005,460,0001,310,000500,000
  投资活动现金流入小计8,666,557,877.998,187,606,299.915,873,914,526.48908,581,299.82
  购建固定资产、无形资产和其他长期资产支付的现金139,696,433.7109,780,064.2441,731,088.09141,764,714.19
  投资支付的现金8,152,400,0007,706,800,0004,325,800,000600,653,917.81
  支付其他与投资活动有关的现金9,150,0005,160,000-500,000
  投资活动现金流出小计8,301,246,433.77,821,740,064.244,367,531,088.09742,918,632
  投资活动产生的现金流量净额365,311,444.29365,866,235.671,506,383,438.39165,662,667.82
三、筹资活动产生的现金流量:
  吸收投资收到的现金-400,000400,000-
  收到其他与筹资活动有关的现金2,000,0002,000,000-2,000,000
  筹资活动现金流入小计2,000,0002,400,000400,0002,000,000
  分配股利、利润或偿付利息支付的现金239,296,365.31239,296,365.3149,100,015.6980,895,868.72
  支付其他与筹资活动有关的现金45,491,454.445,091,550.5623,877,229.1619,604,440.2
  筹资活动现金流出小计284,787,819.71284,387,915.8772,977,244.85100,500,308.92
  筹资活动产生的现金流量净额-282,787,819.71-281,987,915.87-72,577,244.85-98,500,308.92
四、汇率变动对现金及现金等价物的影响-754,789.21164,489.37-485,719.122,812,134.49
五、现金及现金等价物净增加额106,871,31685,965,261.821,474,088,840.956,324,983
  加:期初现金及现金等价物余额160,292,353.03160,292,353.03160,292,353.03103,967,370.03
  期末现金及现金等价物余额267,163,669.03246,257,614.851,634,381,193.93160,292,353.03
补充资料:
  净利润-57,367,849.85-104,951,340.17
  固定资产和投资性房地产折旧-35,910,478.45-65,112,495.39
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-35,910,478.45-65,112,495.39
  无形资产摊销-545,791.26-1,150,813.01
  处置固定资产、无形资产和其他长期资产的损失-36,368.8--
  固定资产报废损失---68,204.12
  投资损失--36,233,619.1--108,578,694.29
  递延所得税--11,229,942.75-23,253,017.46
    递延所得税负债增加--11,229,942.75-23,253,017.46
  存货的减少--48,655,213.17--38,376,082.53
  经营性应收项目的减少-52,316,936.62--42,171,459.22
  经营性应付项目的增加--48,300,570.23--19,701,184.77
  现金的期末余额-246,257,614.85-160,292,353.03
  减:现金的期初余额-160,292,353.03-103,967,370.03
  现金及现金等价物的净增加额-85,965,261.82-56,324,983
公告日期2025-10-272025-08-292025-04-292025-04-29
审计意见(境内)标准无保留意见
TOP↑